Výsledky vyhledávání - "Suttida Puksuriwong"

Akademický článek

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

Autor: Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn, Piengthong Narakorn, Somchaiya Surichan, Sumalee Prangpratanporn, Suttida Puksuriwong, Steven Lamola, Laina D. Mercer, Rama Raghunandan, Weina Sun, Yonghong Liu, Juan Manuel Carreño, Rami Scharf, Weerapong Phumratanaprapin, Fatima Amanat, Luc Gagnon, Ching-Lin Hsieh, Ruangchai Kaweepornpoj, Sarwat Khan, Manjari Lal, Stephen McCroskery, Jason McLellan, Ignacio Mena, Marcia Meseck, Benjaluck Phonrat, Yupa Sabmee, Ratsamikorn Singchareon, Stefan Slamanig, Nava Suthepakul, Johnstone Tcheou, Narumon Thantamnu, Sompone Theerasurakarn, Steven Tran, Thanakrit Vilasmongkolchai, Jessica A White, Nina Bhardwaj, Adolfo Garcia-Sastre, Peter Palese, Florian Krammer, Kittisak Poopipatpol, Ponthip Wirachwong, Richard Hjorth, Bruce L Innis

Publikováno v: EClinicalMedicine, Vol 45, Iss , Pp 101323- (2022)

Summary: Background: Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based recombinant Newcastle disease virus vaccine expressing the spike (S) prote

Externí odkaz: https://doaj.org/article/ffb4f5b1dc304f6186c8f2d2d34e14cf

Zobrazit plný text záznamu

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

Publikováno v: medRxiv

SummaryBackgroundProduction of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based Newcastle disease virus vaccine expressing the spike protein of severe acute r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ff513b3ce313d4926c1fba4605cb46
https://doi.org/10.1101/2021.09.17.21263758

Zobrazit plný text záznamu

Modified Vaccinia Ankara–Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue

Autor: Sam Leong, Qibo Zhang, Muhammad S Ahmed, Ravi Sharma, Suttida Puksuriwong, Teresa Lambe, Sarah C. Gilbert, Madhan Krishnan, Paul S. McNamara

Publikováno v: The Journal of Infectious Diseases
The Journal of infectious diseases

Background Increasing evidence supports a critical role of CD8+ T-cell immunity against influenza. Activation of mucosal CD8+ T cells, particularly tissue-resident memory T (TRM) cells recognizing conserved epitopes would mediate rapid and broad prot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc0fd7df807ab28ac1f3d7cabd9aac4
https://doi.org/10.1093/infdis/jiz593

Zobrazit plný text záznamu

Novel MVA-based vaccine expressing influenza NP and M1 activates cross-reactive T cell responses in human nasopharynx-associated lymphoid tissue (NALT)

Autor: Suttida Puksuriwong, Muhammad Shamsher Ahmed, Ravi Sharma, Madhan Krishnan, Salil Sood, Max McCormick, Sam Leong, Teresa Lambe, Paul McNamara, Sarah C. Gilbert, Qibo Zhang

Publikováno v: The Journal of Immunology. 200:180.17-180.17

Influenza virus infection continues to cause widespread morbidity and mortality, resulting in major challenges for healthcare systems. Current influenza vaccines are of limited efficacy against mismatched or emerging new virus strains. Recent efforts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5e1ab8110b7c0105747fe89c214fc6b4
https://doi.org/10.4049/jimmunol.200.supp.180.17

Zobrazit plný text záznamu

Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines

Autor: Francesca Ferrara, Paul S. McNamara, Sarah C. Gilbert, Priya Achar, Navdeep Upile, Helen Beer, Suttida Puksuriwong, Qibo Zhang, Muhammad S Ahmed, Ravi Sharma, Teresa Lambe, Jennifer Mullin, Nigel J. Temperton

Publikováno v: Vaccine. 34(14)

Recent efforts have been focused on the development of vaccines that could induce broad immunity against influenza virus, either through T cell responses to conserved internal antigens or B cell response to cross-reactive haemagglutinin (HA). We stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cffc5c0e9426535492b494ccad89dfb
https://pubmed.ncbi.nlm.nih.gov/26902548

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání